Where and How to Dispose of Unused Medicines
Recently the U.S. Food and Administration release an article about disposing of unused medicines. “Is your medicine cabinet full of expired drugs or medications you…
Medications
FDA Revokes EUA for Bamlanivimab
On April 16, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when…
Ivermectin Against COVID-19?
The US Food and Drug Administration (FDA) recently writes an article about a growing interest in a drug called ivermectin to treat humans with COVID-19….
Lilly’s Bamlanivimab and Etesevimab
On March 10, Eli Lilly and Company announced new data from the randomized, double-blind, placebo-controlled BLAZE-1 Phase 3 study, demonstrating bamlanivimab (LY-CoV555) 700 mg and…
New Blood Pressure Management Guidelines
On February 23, the Johns Hopkins Bloomberg School of Public Health (JHBS) published the research results recommendation for more intensive blood pressure management with in…
FDA Approves Cosela
On February 12, the U.S. Food and Drug Administration (FDA) approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of…
Potential Risks Associated With Remdesivir Drug Products
After the approvement of a new drug application (NDA) for Veklury (remdesivir), a drug indicated for adults and pediatric patients (12 years of age and…
FDA On The Age Of Individualized Medicine
Recently, it was announced about new steps to provide clarity on developing new drug products in the age of individualized medicine by U.S. Food and…
Moderna COVID-19 Vaccine Candidate
On November 30, 2020, Moderna, Inc., a biotechnology company that specializes in RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines…
Impel Neuropharma Acute Migraine Treatment
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…